Compare $BAX vs $RMD | Chartloom

Compare

$BAX vs $RMD

Baxter International Inc · Resmed Inc

BAX

Baxter International Inc

RMD

Resmed Inc

Compare $BAX vs $RMD

Comparing Baxter International Inc and Resmed Inc

BAXBaxter International Inc

RMDResmed Inc

BAXBaxter International Inc

Market cap

$12.58B

P/E (TTM)

—

Forward P/E (NTM)

11.35x

Forward P/S (NTM)

1.06x

Rev growth (TTM)

5.4%

YTD performance

24.9%

52W performance

7.0%

FCF yield

6.5%

RMDResmed Inc

Market cap

$33.37B

P/E (TTM)

21.89x

Forward P/E (NTM)

18.79x

Forward P/S (NTM)

5.69x

Rev growth (TTM)

9.9%

YTD performance

-6.0%

52W performance

-18.5%

FCF yield

4.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BAX

RMD

Detailed metrics comparison

BAX

Baxter International Inc

RMD

Resmed Inc

Market Cap

BAX$12.58B

RMD$33.37B

Enterprise Value

BAX$19.89B

RMD$32.56B

Price

BAX$24.35

RMD$230.05

P/E Ratio

BAXN/A

RMD21.89x

P/S Ratio

BAX1.10x

RMD5.90x

EV/Sales

BAX1.73x

RMD5.76x

EV/EBITDA

BAX13.60x

RMD15.39x

P/B Ratio

BAX1.96x

RMD4.79x

P/FCF Ratio

BAX15.43x

RMD20.49x

EV/FCF

BAX24.40x

RMD19.99x

PEG Ratio

BAXN/A

RMD2.17x

Forward P/E (NTM)

BAX11.35x

RMD18.79x

Forward P/S (NTM)

BAX1.06x

RMD5.69x

Revenue (TTM)

BAX$11.47B

RMD$5.65B

Revenue Growth (YoY)

BAX5.4%

RMD9.9%

Forward Rev Growth

BAX2.1%

RMD6.7%

Gross Margin (TTM)

BAX30.7%

RMD61.1%

Operating Margin (TTM)

BAX0.0%

RMD33.4%

EBITDA Margin (TTM)

BAX12.7%

RMD37.4%

Net Margin (TTM)

BAX-9.3%

RMD26.9%

FCF Margin (TTM)

BAX7.1%

RMD28.8%

Net Income (TTM)

BAX$-1.06B

RMD$1.52B

FCF (TTM)

BAX$815M

RMD$1.63B

EPS (TTM)

BAX-$2.05

RMD$10.51

ROE (TTM)

BAX-1660.0%

RMD23.9%

ROA (TTM)

BAX-527.0%

RMD17.6%

ROIC (TTM)

BAX-669.0%

RMD21.6%

Cash

BAX$2.15B

RMD$1.47B

Debt

BAX$9.46B

RMD$659M

Net Cash/Debt

BAX$-7.31B

RMD$810M

Current Ratio (TTM)

BAX1.95x

RMD3.10x

Quick Ratio (TTM)

BAX1.15x

RMD2.12x

Debt/Equity (TTM)

BAX1.52x

RMD0.10x

Debt/Assets (TTM)

BAX0.0%

RMD0.0%

Interest Coverage (TTM)

BAXN/A

RMDN/A

Net Debt/EBITDA (TTM)

BAX0.00x

RMD0.00x

Beta

BAX0.67

RMD0.78

52W Performance

BAX7.0%

RMD-18.5%

YTD Performance

BAX24.9%

RMD-6.0%

% from 52W High

BAX-18.8%

RMD-19.0%

% from 52W Low

BAX54.8%

RMD27.6%

Asset Turnover (TTM)

BAX0.57x

RMD0.65x

FCF Yield (TTM)

BAX6.5%

RMD4.9%

Earnings Yield (TTM)

BAX-8.5%

RMD4.6%

Dividend Yield (TTM)

BAX1.5%

RMD1.1%

Rule of 40

BAX12.5

RMD38.7

EV/GP/RG

BAX1.72

RMD2.54

Ticker research

View BAX research View RMD research

Metric	BAX Baxter International Inc	RMD Resmed Inc
Market & Valuation
Market Cap	$12.58B	$33.37B
Enterprise Value	$19.89B	$32.56B
Price	$24.35	$230.05
P/E Ratio	N/A	21.89x
P/S Ratio	1.10x	5.90x
EV/Sales	1.73x	5.76x
EV/EBITDA	13.60x	15.39x
P/B Ratio	1.96x	4.79x
P/FCF Ratio	15.43x	20.49x
EV/FCF	24.40x	19.99x
PEG Ratio	N/A	2.17x
Forward P/E (NTM)	11.35x	18.79x
Forward P/S (NTM)	1.06x	5.69x
Revenue & Growth
Revenue (TTM)	$11.47B	$5.65B
Revenue Growth (YoY)	5.4%	9.9%
Forward Rev Growth	2.1%	6.7%
Profitability
Gross Margin (TTM)	30.7%	61.1%
Operating Margin (TTM)	0.0%	33.4%
EBITDA Margin (TTM)	12.7%	37.4%
Net Margin (TTM)	-9.3%	26.9%
FCF Margin (TTM)	7.1%	28.8%
Net Income (TTM)	$-1.06B	$1.52B
FCF (TTM)	$815M	$1.63B
EPS (TTM)	-$2.05	$10.51
ROE (TTM)	-1660.0%	23.9%
ROA (TTM)	-527.0%	17.6%
ROIC (TTM)	-669.0%	21.6%
Financial Health
Cash	$2.15B	$1.47B
Debt	$9.46B	$659M
Net Cash/Debt	$-7.31B	$810M
Current Ratio (TTM)	1.95x	3.10x
Quick Ratio (TTM)	1.15x	2.12x
Debt/Equity (TTM)	1.52x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	0.78
52W Performance	7.0%	-18.5%
YTD Performance	24.9%	-6.0%
% from 52W High	-18.8%	-19.0%
% from 52W Low	54.8%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.65x
FCF Yield (TTM)	6.5%	4.9%
Earnings Yield (TTM)	-8.5%	4.6%
Dividend Yield (TTM)	1.5%	1.1%
Other
Rule of 40	12.5	38.7
EV/GP/RG	1.72	2.54
Ticker research	View BAX research	View RMD research

Valuation

P/E Ratio

RMD

21.89x

P/S Ratio

BAX

1.10x

RMD

5.90x

EV/FCF

RMD

19.99x

BAX

24.40x

Growth & revenue

Revenue Growth TTM

RMD

9.9%

BAX

5.4%

Forward Revenue Growth

RMD

6.7%

BAX

2.1%

Profitability & performance

Gross Margin

RMD

61.1%

BAX

30.7%

ROE

RMD

23.9%

BAX

-1660.0%

FCF Yield %

BAX

6.5%

RMD

4.9%

52-Week Performance

BAX

7.0%

RMD

-18.5%

Detailed metrics comparison

BAX

Baxter International Inc

RMD

Resmed Inc

Market Cap

BAX$12.58B

RMD$33.37B

Enterprise Value

BAX$19.89B

RMD$32.56B

Price

BAX$24.35

RMD$230.05

P/E Ratio

BAXN/A

RMD21.89x

P/S Ratio

BAX1.10x

RMD5.90x

EV/Sales

BAX1.73x

RMD5.76x

EV/EBITDA

BAX13.60x

RMD15.39x

P/B Ratio

BAX1.96x

RMD4.79x

P/FCF Ratio

BAX15.43x

RMD20.49x

EV/FCF

BAX24.40x

RMD19.99x

PEG Ratio

BAXN/A

RMD2.17x

Forward P/E (NTM)

BAX11.35x

RMD18.79x

Forward P/S (NTM)

BAX1.06x

RMD5.69x

Revenue (TTM)

BAX$11.47B

RMD$5.65B

Revenue Growth (YoY)

BAX5.4%

RMD9.9%

Forward Rev Growth

BAX2.1%

RMD6.7%

Gross Margin (TTM)

BAX30.7%

RMD61.1%

Operating Margin (TTM)

BAX0.0%

RMD33.4%

EBITDA Margin (TTM)

BAX12.7%

RMD37.4%

Net Margin (TTM)

BAX-9.3%

RMD26.9%

FCF Margin (TTM)

BAX7.1%

RMD28.8%

Net Income (TTM)

BAX$-1.06B

RMD$1.52B

FCF (TTM)

BAX$815M

RMD$1.63B

EPS (TTM)

BAX-$2.05

RMD$10.51

ROE (TTM)

BAX-1660.0%

RMD23.9%

ROA (TTM)

BAX-527.0%

RMD17.6%

ROIC (TTM)

BAX-669.0%

RMD21.6%

Cash

BAX$2.15B

RMD$1.47B

Debt

BAX$9.46B

RMD$659M

Net Cash/Debt

BAX$-7.31B

RMD$810M

Current Ratio (TTM)

BAX1.95x

RMD3.10x

Quick Ratio (TTM)

BAX1.15x

RMD2.12x

Debt/Equity (TTM)

BAX1.52x

RMD0.10x

Debt/Assets (TTM)

BAX0.0%

RMD0.0%

Interest Coverage (TTM)

BAXN/A

RMDN/A

Net Debt/EBITDA (TTM)

BAX0.00x

RMD0.00x

Beta

BAX0.67

RMD0.78

52W Performance

BAX7.0%

RMD-18.5%

YTD Performance

BAX24.9%

RMD-6.0%

% from 52W High

BAX-18.8%

RMD-19.0%

% from 52W Low

BAX54.8%

RMD27.6%

Asset Turnover (TTM)

BAX0.57x

RMD0.65x

FCF Yield (TTM)

BAX6.5%

RMD4.9%

Earnings Yield (TTM)

BAX-8.5%

RMD4.6%

Dividend Yield (TTM)

BAX1.5%

RMD1.1%

Rule of 40

BAX12.5

RMD38.7

EV/GP/RG

BAX1.72

RMD2.54

Ticker research

View BAX research View RMD research

Metric	BAX Baxter International Inc	RMD Resmed Inc
Market & Valuation
Market Cap	$12.58B	$33.37B
Enterprise Value	$19.89B	$32.56B
Price	$24.35	$230.05
P/E Ratio	N/A	21.89x
P/S Ratio	1.10x	5.90x
EV/Sales	1.73x	5.76x
EV/EBITDA	13.60x	15.39x
P/B Ratio	1.96x	4.79x
P/FCF Ratio	15.43x	20.49x
EV/FCF	24.40x	19.99x
PEG Ratio	N/A	2.17x
Forward P/E (NTM)	11.35x	18.79x
Forward P/S (NTM)	1.06x	5.69x
Revenue & Growth
Revenue (TTM)	$11.47B	$5.65B
Revenue Growth (YoY)	5.4%	9.9%
Forward Rev Growth	2.1%	6.7%
Profitability
Gross Margin (TTM)	30.7%	61.1%
Operating Margin (TTM)	0.0%	33.4%
EBITDA Margin (TTM)	12.7%	37.4%
Net Margin (TTM)	-9.3%	26.9%
FCF Margin (TTM)	7.1%	28.8%
Net Income (TTM)	$-1.06B	$1.52B
FCF (TTM)	$815M	$1.63B
EPS (TTM)	-$2.05	$10.51
ROE (TTM)	-1660.0%	23.9%
ROA (TTM)	-527.0%	17.6%
ROIC (TTM)	-669.0%	21.6%
Financial Health
Cash	$2.15B	$1.47B
Debt	$9.46B	$659M
Net Cash/Debt	$-7.31B	$810M
Current Ratio (TTM)	1.95x	3.10x
Quick Ratio (TTM)	1.15x	2.12x
Debt/Equity (TTM)	1.52x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	0.78
52W Performance	7.0%	-18.5%
YTD Performance	24.9%	-6.0%
% from 52W High	-18.8%	-19.0%
% from 52W Low	54.8%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.65x
FCF Yield (TTM)	6.5%	4.9%
Earnings Yield (TTM)	-8.5%	4.6%
Dividend Yield (TTM)	1.5%	1.1%
Other
Rule of 40	12.5	38.7
EV/GP/RG	1.72	2.54
Ticker research	View BAX research	View RMD research